Literature DB >> 27311727

Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India.

Ravindra Pramod Deshpande1, Deepak Babu1, Manas Panigrahi2, Y B V K Chandra Sekhar2, Phanithi Prakash Babu3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27311727     DOI： 10.1007/s11060-016-2183-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  15 in total

1.  No circulating cytomegalovirus in five patients with glioblastoma multiforme.

Authors:  Steven Lehrer; Vincent Labombardi; Sheryl Green; Melissa S Pessin-Minsley; Isabelle M Germano; Kenneth E Rosenzweig
Journal:  Anticancer Res       Date:  2011-03       Impact factor: 2.480

Review 2.  Microsurgical treatment of temporal lobe cavernomas.

Authors:  Juri Kivelev; Mika Niemelä; Göran Blomstedt; Reina Roivainen; Martin Lehecka; Juha Hernesniemi
Journal:  Acta Neurochir (Wien)       Date:  2010-09-26       Impact factor: 2.216

3.  Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India.

Authors:  Rakesh Jalali; Debnarayan Datta
Journal:  J Neurooncol       Date:  2007-11-15       Impact factor: 4.130

4.  Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management.

Authors:  Ranjith Babu; Richa Sharma; Jacob H Bagley; Jeffrey Hatef; Allan H Friedman; Cory Adamson
Journal:  J Neurosurg       Date:  2013-02-22       Impact factor: 5.115

5.  Neuro-oncology: The many challenges of treating elderly glioblastoma patients.

Authors:  Martin J van den Bent; Jacoline E Bromberg
Journal:  Nat Rev Neurol       Date:  2015-05-19       Impact factor: 42.937

6.  No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics.

Authors:  Steven Lehrer; Sheryl Green; Lakshmi Ramanathan; Kenneth Rosenzweig; Vincent Labombardi
Journal:  Anticancer Res       Date:  2012-03       Impact factor: 2.480

7.  Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base.

Authors:  F G Davis; B J McCarthy; M S Berger
Journal:  Neuro Oncol       Date:  1999-07       Impact factor: 12.300

8.  Meningioma grading: an analysis of histologic parameters.

Authors:  A Perry; S L Stafford; B W Scheithauer; V J Suman; C M Lohse
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

Review 9.  Epidemiology of brain tumors.

Authors:  James L Fisher; Judith A Schwartzbaum; Margaret Wrensch; Joseph L Wiemels
Journal:  Neurol Clin       Date:  2007-11       Impact factor: 3.806

Review 10.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088
View more
  4 in total

1.  Prognostic Significance of Anatomic Origin and Evaluation of Survival Statistics of Astrocytoma Patients-a Tertiary Experience.

Authors:  Ravindra Pramod Deshpande; Chandrasekhar Y B V K; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Indian J Surg Oncol       Date:  2018-10-30

2.  Profiling of microRNAs modulating cytomegalovirus infection in astrocytoma patients.

Authors:  Ravindra Pramod Deshpande; Manas Panigrahi; Chandrasekhar Y B V K; Phanithi Prakash Babu
Journal:  Neurol Sci       Date:  2018-08-08       Impact factor: 3.307

3.  Region-Specific Dok2 Overexpression Associates with Poor Prognosis in Human Astrocytoma.

Authors:  Ravindra Pramod Deshpande; Y B V K Chandra Sekhar; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

4.  SIRP Alpha Protein Downregulates in Human Astrocytoma: Presumptive Involvement of Hsa-miR-520d-5p and Hsa-miR-520d-3p.

Authors:  Ravindra Pramod Deshpande; Y B V K Chandra Sekhar; Manas Panigrahi; Phanithi Prakash Babu
Journal:  Mol Neurobiol       Date:  2016-11-29       Impact factor: 5.590
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.